about
A cell-based high-content screening assay reveals activators and inhibitors of cancer cell invasionStudies on Taxol biosynthesis: preparation of taxadiene-diol and triol derivatives by deoxygenation of taxusinTaxol biosynthesis: molecular cloning of a benzoyl-CoA:taxane 2alpha-O-benzoyltransferase cDNA from taxus and functional expression in Escherichia coliPaclitaxel: new uses for an old drug.Synthetic biology approaches in drug discovery and pharmaceutical biotechnology.Taxol biosynthesis and molecular geneticsStudies on Taxol® Biosynthesis. Preparation and Tritium Labeling of Biosynthetic intermediates by Deoxygenation of a Taxadiene Tetra-acetate Obtained from Japanese Yew.Novel water-soluble polyurethane nanomicelles for cancer chemotherapy: physicochemical characterization and cellular activities.Src family kinases and paclitaxel sensitivity.Paclitaxel-conjugated PEG and arginine-grafted bioreducible poly (disulfide amine) micelles for co-delivery of drug and gene.PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel.Hydrotropic polymeric micelles for enhanced paclitaxel solubility: in vitro and in vivo characterizationDevelopment of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation.Taxol biosynthesis: Identification and characterization of two acetyl CoA:taxoid-O-acetyl transferases that divert pathway flux away from Taxol production.Oil-filled lipid nanoparticles containing 2'-(2-bromohexadecanoyl)-docetaxel for the treatment of breast cancerWeekly administration of sagopilone (ZK-EPO), a fully synthetic epothilone, in patients with refractory solid tumours: results of a phase I trial.Design and evaluation of a PEGylated lipopeptide equipped with drug-interactive motifs as an improved drug carrier.Differential cell responses to nanoparticle docetaxel and small molecule docetaxel at a sub-therapeutic dose range.A cell-based pharmacokinetics assay for evaluating tubulin-binding drugsDevelopment and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivo.Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: in vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor.The role of TLR4 in the paclitaxel effects on neuronal growth in vitro.
P2860
Q24627610-1CF43B92-DBBB-4B59-B5AA-7D17BCD344ADQ24655561-CAD20E40-82C7-4B4D-A750-DF2275659C80Q24669544-CA528A98-3298-41E4-9A76-7A8A44AE75D7Q27691306-47B44DB6-2D56-4053-AD0B-4257C6FE60AEQ33557182-EF57FEDF-1186-4174-B854-C8E54E57A72CQ33630392-3E9F1CAA-8D12-41C8-B72B-4F637DD64A6EQ33714360-B4E918C0-F69F-4CDE-848C-1BF50015CEE1Q34119493-1511A5E2-6F23-422F-A1B4-479C0ECAC847Q35214722-884321A8-D5E9-4F1D-90FD-21B3D1EF77ACQ36203354-E2956BA0-0F08-40C4-AA23-44E7290F7218Q36759098-61B9B702-C6DE-44E5-A421-082D0751B6FEQ36868666-BCC32513-3D3E-436A-ADEF-07FF7E87D88FQ37248679-45BC4D1F-3AF6-443D-BA9D-008C0ED6F7D0Q37357119-5F4580B4-FA94-4104-9C0C-F746EC5B1E5DQ37381382-95D6B8F1-065C-4838-8177-AE12A25F0140Q37401487-9B6A58A3-2A5C-40AC-B01A-A4F55E5B699BQ37469417-1BC009AA-14CE-449C-87A1-200A17B5D8ADQ37549416-2E04E8B9-54C4-4693-A113-B84D8521D4C7Q38561970-AF4D92BF-AAAF-46D8-A21B-F2D25BB2DCD7Q38885649-78559C0F-421E-4B49-B337-940302B3B276Q39430827-A768B287-959E-422F-A8D1-1CDC69BCE037Q43245268-892FA8BB-24CE-4D16-ACAE-45028B015B1A
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Clinical overview of the taxanes.
@en
type
label
Clinical overview of the taxanes.
@en
prefLabel
Clinical overview of the taxanes.
@en
P1433
P1476
Clinical overview of the taxanes
@en
P2093
B R Goldspiel
P304
P407
P433
P577
1997-09-01T00:00:00Z